Analysis of Liver Fibrosis Degree with APRI Score and FIB-4 Index on Patients with Non-Alcoholic Fatty Liver Disease
DOI:
https://doi.org/10.24293/ijcpml.v26i2.1414Keywords:
Liver fibrosis, APRI score, FIB-4 indexAbstract
Liver fibrosis is the accumulation of Extracellular Matrix Protein (EMP) scar tissue after acute or chronic liver injury. Liver biopsy is the gold standard test for evaluating liver fibrosis in patients with Non-Alcoholic Fatty Liver Disease (NAFLD). This diagnostic method is invasive, painful, and complicated in rare cases; thus the noninvasive methods such as laboratory tests and radiology had been proposed to assess liver fibrosis in NAFLD and are expected to overcome the limitations of liver biopsy. This method consists of aspartate Aminotransferase to the Platelet Ratio Index (APRI) and fibrosis-4 (FIB-4).This
research was retrospective cross-sectional performed at Dr. Wahidin Sudirohusodo Hospital Makassar involving 63 subjects from January to June 2018. The correlated variables were presented in categorical and numerical data and the Pearson correlation test was used to determine the compatibility of APRI score and FIB-4 index with Fibroscan result in patients with NAFLD. A highly significant positive correlation (p <0.001) was found between APRI score and Fibroscan (correlation value = 45.8%), APRI score and FIB-4 index (correlation value = 91.8%), FIB-4 index and Fibroscan (correlation value = 47.6%). The score of Aminotransferase to platelet ratio index score and FIB-4 index could be an alternative method instead of a liver biopsy to predict the degree of fibrosis in patients with NAFLD.
Downloads
References
Ahmet Aslan, et al. Effect of Nonalcoholic Fatty Liver Disease on the Hepatic Vein and Artery. Research Article; 2014.p 1-4
Kareem Hassan, et al. Nonalcoholic Fatty Liver Disease: A Comprehensiv Review of a Growing Epidemic. World Journal of Gastroenterology; 2014. p.12082-101
Elena Buzzetti, Rosa L et al. Noninvasive Assessment of Fibrosis in Patients with Nonalcoholic Fatty Liver Disease. International Journal of Endocrinology, Vol.XII; 2015. p 1-4.
Linda Ferrel. Update on Staging of Fibrosis and Cirrhosis. University of California ;2013. p.1-22.
Hind I. Fallatah, Noninvasive Biomarkers of Liver Fibrosis, Advance in Hepatology; 2014. p 1-15.
Thad Wilkins, Altaf Tadkod et al, Nonalcoholic Fatty Liver Disease: Diagnosis and Management. American Family Physician, 2013.p. 35-42.
Surastik Agrawal and Ajay K Duseja. Non-Alcoholic Fatty Liver Disease: East Versus West. Journal of Ccinical and Experimental.Hepatology; 2012 Vol 2. p.122-134.
Mustakin. Analisis Derajat Fibrosis Hati dengan Fibroscan, FIB4 Indeks, King Score, dan APRI Score pada pasien penyakit hepatitis kronis. Departemen Ilmu Patologi Klinik. Universitas Hassanudin. 2015.
Atsushi Nakajima, Yoshio S et al. Non-invasive scoring systems for predicting NASH in Japan: evidence from Japan Study Group of NAFLD, Integrative Molecular Medicine; 2015. p.145-149.
Becker L, Evaluation and Staging of Liver Fibrosis; 2015. p. 1-16.
Downloads
Submitted
Accepted
Published
How to Cite
Issue
Section
License
Copyright (c) 2020 INDONESIAN JOURNAL OF CLINICAL PATHOLOGY AND MEDICAL LABORATORY
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.